Bulun SE

No ORCID on file · 90 papers in corpus · active 1996-2025

Study types

  • review 34
  • article 30
  • other 11
  • letter 4

Condition tags

  • endometriosis 77
  • infertility 7
  • chronic_pelvic_pain 5
  • adenomyosis 2
  • mesh:D004716 1
  • endometrioma 1
article 2014
PLoS genetics ·doi:10.1371/journal.pgen.1004158

Endometriosis is a gynecological disease defined by the extrauterine growth of endometrial-like cells that cause chronic pain and infertility. The disease is limited to primates that exhibit spontaneous decidualization, and diseased cells a…

other 2014
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719113497283

UNLABELLED: Steroidogenic factor 1 (SF-1), a transcriptional factor essential for estrogen biosynthesis, is undetectable in endometrial stromal cells and aberrantly expressed in endometriotic stromal cells. OBJECTIVE: We tried to gain furt…

letter 2014
Fertility and sterility ·doi:10.1016/j.fertnstert.2014.01.044
2014
Biology of reproduction ·doi:10.1095/biolreprod.114.123794

Tissue-specific (or somatic) stem cells constitute a subset of cells residing in normal adult tissues. By undergoing asymmetric division, they retain their ability to self-renew while producing daughter cells that go on to differentiate and…

review 2013
Endocrine reviews ·doi:10.1210/er.2012-1043

Progesterone receptor (PR) mediates the actions of the ovarian steroid progesterone, which together with estradiol regulates gonadotropin secretion, prepares the endometrium for implantation, maintains pregnancy, and differentiates breast t…

review 2013
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2013-1328

CONTEXT: Anovulation is likely responsible for 20% of female infertility. Although clomiphene citrate remains the first-line therapy for ovulation induction in anovulatory patients who are not estrogen-deficient and to treat unexplained inf…

other 2012
Fertility and sterility ·doi:10.1016/j.fertnstert.2012.03.030

OBJECTIVE: To define altered gene expression networks in endometriosis. DESIGN: Experiments using endometriotic tissues and primary cells. SETTING: Division of Reproductive Biology Research, Northwestern University. PATIENT(S): Premenopa…

review 2012
Fertility and sterility ·doi:10.1016/j.fertnstert.2012.08.053

ObjectiveTo review the use of aromatase inhibitors (AIs) for the treatment of endometriosis.DesignLiterature review.Conclusion(s)Most studies show that in reproductive-age women, the combination of AI with conventional therapy alleviates en…

article 2012
Fertility and sterility ·doi:10.1016/j.fertnstert.2012.11.021

ObjectiveTo determine the effect of inhibiting aromatase activity on endometrial lesion growth and aromatase expression in a baboon model of induced endometriosis.DesignProspective study.SettingPrimate research institute.Animal(s)Sixteen ol…

letter 2012
Nature medicine ·doi:10.1038/nm.2855
2012
PloS one ·doi:10.1371/journal.pone.0029021

BackgroundProgesterone, via its nuclear receptor (PR), exerts an overall tumorigenic effect on both uterine fibroid (leiomyoma) and breast cancer tissues, whereas the antiprogestin RU486 inhibits growth of these tissues through an unknown m…

review 2012
Seminars in reproductive medicine ·doi:10.1055/s-0031-1299596

Endometriosis is an estrogen-dependent disease. The biologically active estrogen, estradiol, aggravates the pathological processes (e.g., inflammation and growth) and the symptoms (e.g., pain) associated with endometriosis. Abundant quantit…

other 2011
Fertility and sterility ·doi:10.1016/j.fertnstert.2011.07.1136

OBJECTIVE: To evaluate the use of an aromatase inhibitor for the treatment of endometriosis-related chronic pelvic pain. DESIGN: Retrospective analysis. SETTING: Academic medical center outpatient reproductive endocrinology clinic. PATIE…

2011
Lung cancer (Amsterdam, Netherlands) ·doi:10.1016/j.lungcan.2011.01.003

In humans, aromatase (CYP19) gene expression is regulated via alternative promoters. Activation of each promoter gives rise to a CYP19 mRNA species with a unique 5'-untranslated region. Inhibition of aromatase has been reported to downregul…

article 2011
Human Reproduction ·doi:10.1093/humrep/der172

BACKGROUND: Retinoic acid (RA) regulates key biological processes, including differentiation, apoptosis and cell survival. RA mediates induction of 17 beta-hydroxysteroid dehydrogenase type 2 mRNA, catalyzing the conversion of estradiol to …

article 2011
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719111404614

UnlabelledEndometriosis is an estrogen-dependent disease. Steroidogenic factor 1 (SF-1), a transcription factor, is essential for the activation of multiple steroidogenic genes for estrogen biosynthesis in endometriosis-derived stromal cell…

review 2010
Seminars in reproductive medicine ·doi:10.1055/s-0029-1242992

Estradiol (E2) stimulates the growth and inflammation in the ectopic endometriotic tissue that commonly resides on the pelvic organs. Several clinical and laboratory-based observations are indicative of resistance to progesterone action in …

article 2010
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2010-0459

CONTEXT: Retinoic acid (RA) controls multiple biological processes via exerting opposing effects on cell survival. Retinol uptake into cells is controlled by stimulated by RA 6 (STRA6). RA is then produced from retinol in the cytosol. Parti…

review 2010
Seminars in reproductive medicine ·doi:10.1055/s-0029-1242991

Loss of progesterone signaling in the endometrium may be a causal factor in the development of endometriosis, and progesterone resistance is commonly observed in women with this disease. In endometriotic stromal cells, the levels of progest…

2010
Fertility and sterility ·doi:10.1016/j.fertnstert.2009.11.031

ObjectiveTo evaluate the effects of selective P receptor (PR) modulator CDB4124 on cell proliferation and apoptosis in cultured human uterine leiomyoma smooth muscle (LSM) cells and control myometrial smooth muscle (MSM) cells in matched ut…

review 2009
Human Reproduction ·doi:10.1093/humrep/dep045

In response to the pressing need for more efficacious and safer therapeutics for endometriosis, there have been numerous reports in the last decade of positive results from animal and in vitro studies of various compounds as potential thera…

review 2009
The New England journal of medicine ·doi:10.1056/nejmra0804690

This review emphasizes the participation of estrogen and inflammation in the development of endometriosis. A feedback cycle in which prostaglandins and aromatase activity are prominent allows for the persistence of endometriotic tissue. Kno…

other 2009
Cancer research ·doi:10.1158/0008-5472.CAN-08-1622

Estrogens and selective estrogen receptor (ER) modulators such as tamoxifen are known to increase uterine cell proliferation. Mounting evidence suggests that estrogen signaling is mediated not only by ERalpha and ERbeta nuclear receptors, b…

review 2008
Advances in experimental medicine and biology ·doi:10.1007/978-0-387-78818-0_8

Estrogen has been positively linked to the pathogenesis and growth of three common women's cancers (breast, endometrium and ovary). A single gene encodes the key enzyme for estrogen biosynthesis named aromatase, inhibition of which effectiv…

2008
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2007-2507

ContextControl of aromatase expression in uterine leiomyoma has significant clinical implications because aromatase inhibitors reduce tumor growth and associated irregular uterine bleeding. The mechanisms that regulate aromatase expression …